Medtronic PLC vs Vanguard High Dividend Yield ETF — how do they compare? Medtronic PLC trades at $88.48 (market cap $112.24B), while Vanguard High Dividend Yield ETF trades at $158.75 (market cap $100.80B). The key difference: Medtronic PLC and Vanguard High Dividend Yield ETF are close in size by market cap, and Medtronic PLC pays a 3.28% dividend while Vanguard High Dividend Yield ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Vanguard High Dividend Yield ETF for 139 Days on average.
| MDT | VYM | |
|---|---|---|
Market Cap | $112.24B | $100.80B |
Volume | 105,663,236 | 908,176 |
Sector | Health | — |
52-Week High | $105.35 | $167.03 |
52-Week Low | $73.75 | $137.47 |
Typical Hold Time | 63 Days | 139 Days |
Enterprise Value | $131.58B | — |
Dividend Yield | 3.28% | — |
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.75, up 2.62% today, with strong analyst support (60.8% buy ratings) and a $97.80 consensus price target suggesting 11.5% upside. The stock shows consistent earnings beats in recent quarters and maintains a 49-year dividend growth streak. However, technical indicators signal bearish momentum with resistance near $89-90. Revenue growth accelerated to $33.54B in 2025 with net margins improving to 13.93%, though debt levels have risen to 31.1% of assets.
MDT presents a compelling value opportunity with attractive dividend yield and earnings momentum, but faces near-term technical headwinds and increasing leverage. The upcoming Q3 earnings report and MiniMed separation will be critical catalysts. Investors should weigh the strong fundamental recovery against bearish technical signals and monitor debt management closely.
VYM trades at $158.25, up 0.51% today, with a bearish technical signal from moving averages. The ETF maintains consistent dividend distributions, with the next payment scheduled for September 2026. Recent news highlights VYM's position as a reliable dividend ETF, though some analysts suggest alternative portfolios may offer superior returns. The fund's broad diversification across nearly 600 holdings provides stability but faces criticism for including companies with recent dividend cuts.
VYM offers steady income with moderate yield but faces competition from higher-performing dividend ETFs. Key risks include exposure to companies with potential dividend reductions and underperformance relative to peer strategies. The fund's low expense ratio and diversification remain attractive for conservative income investors seeking reliable quarterly payments.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VYM →